Company: IOBT
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0000950170-25-070956
Chunk: 0

Company: IO Biotech, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Item 1
Chunk 0
---
IO BIOTECH, INC. 

Consolidated Balance Sheets 

(In thousands, except share and per share amounts) 

(unaudited) 

     March 31,2025

     December 31,2024

     Assets

     Current assets

     Cash and cash equivalents
      
     $
     37,086

     $
     60,031

     Prepaid expenses and other current assets

     5,256

     4,920

     Total current assets

     42,342

     64,951

     Restricted cash

     268

     268

     Property and equipment, net

     617

     638

     Right of use lease asset

     1,585

     1,725

     Other non-current assets

     924

     117

     Total non-current assets

     3,394

     2,748

     Total assets
      
     $
     45,736

     $
     67,699

     Liabilities and stockholders’ equity

     Current liabilities

     Accounts payable
      
     $
     5,198

     $
     4,661

     Lease liability - current

     735

     717

     Accrued expenses and other current liabilities

     12,353

     14,108

     Total current liabilities

     18,286

     19,486

     Lease liability - non-current

     1,028

     1,198

                    Total non-current liabilities

     1,028

     1,198

     Total liabilities

     19,314

     20,684

     Commitments and contingencies (Note 10)

     Stockholders’ equity

     Preferred stock, par value of $0.001 per share; 5,000,000 shares authorized, no shares issued and outstanding as of March 31, 2025 and December 31, 2024

     —

     —

     Common stock, par value of $0.001 per share; 300,000,000 shares authorized at March 31, 2025 and December 31, 2024; 65,880,914 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively

     66

     66

     Additional